China Supplied Faulty Coronavirus Test Kits to Spain, Czech Republic
The majority of rapid test coronavirus test kits supplied by China to Spain and the Czech Republic are faulty, local news outlets reported.
150,000 portable, quick coronavirus test kits China delivered to the Czech Republic earlier this month which can produce a result in 10 minutes are less accurate than other tests, according to local Czech news site Expats.cz.
The country’s Health Ministry paid $546,000 for 100,000 of the test kits, while the Interior Ministry paid for the other 50,000.
Meanwhile in Spain, The virus outbreak has killed more than 4,000 patients in Spain as of Thursday, surpassing the death toll in China, and infected more than 50,000 people, the second-highest number of fatalities in the world after Italy, found that the rapid coronavirus test kits it purchased from Chinese company Bioeasy only correctly identified 30 percent of virus cases, according to Spanish newspaper El Pais.
Studies performed on the tests which discovered the high error rate caused the Spanish Society of Infectious Diseases and Clinical Microbiology to recommend officially that the tests not be used.
The director Spain’s Center for Health Alerts and Emergencies, Fernando Simón, said Spain tested 9,000 of the test kits and will return them based on their high error rate.
China will replace some coronavirus test kits it exported to Spain after the Spanish government deemed them too inaccurate to be used to diagnose patients.
The Chinese embassy in Spain claimed the Bioeasy products are not included in the products.
China has been supplying to countries where the virus has broken out.
It comes as China is apparently trying to fill the void of American leadership in Europe during the coronavirus crisis as Chinese public officials work to shift the blame of the virus from China to other countries including America.
The problem isn’t confined to China. In the United States, an initial coronavirus test kit rolled out by government officials contained a faulty indicator. But the sheer size of China’s response and the lingering effects of its own coronavirus containment efforts have complicated the process.
“Every time when something major happens in society like this virus outbreak, there is a lot of demand and different kinds of companies try to get in,” said Cody Zhang, the chief executive officer of a start-up seeking certification for its own products, including a disinfecting robot. “It becomes hard at the beginning to figure out which ones are good and which ones are bad.”